We ⁦Neyts Virology Lab⁩ show omicron #SARSco2 does not readily infect lungs of hamsters (contrast to other strains). Reasons may be 1) too well adapted to man 2) infects rather the upper respiratory tract 3) is less pathogenic or, combination of above. biorxiv.org/content/10.110…

With yet another in vivo study of Omicron infection today, it sure is looking that this variant has less virulence, less chance of inducing Covid pneumonia👍 New report: biorxiv.org/content/10.110… Added to our immunity wall and T cell defense, this is all good.

5 Studies, 5 Figures. All consistent, independent replications in vivo, in vitro. Omicron can't infect lungs or lung cells as well as prior variants. KU Leuven The Sato Lab (Kei Sato) Gupta Lab HKU Medicine University of Liverpool

Our Preprint now published. SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19 biorxiv.org/content/10.110… James Stewart 🦠🌿 #omicron #SARSCoV2 Andrew Owen

New data from our amazing team showing Omicron produces less severe disease than Pango B and Delta SARS-CoV-2 variants in a mouse model 🐭 biorxiv.org/content/10.110…

We’re off. #BristolBalloonFiesta #BristolBalloon

Fab display this AM from Bedminster Down. #BristolBalloonFiesta #BristolBalloon sheep followed by a wolf 😎

Our review on the role of non-canonical autophagy in control of infection published today Inst of Infection Veterinary & Ecological Sciences University of Liverpool News Quadram Institute #influenza science.org/doi/10.1126/sc…

Just published nature An approved, inexpensive, off-patent drug for liver disease, UDCA, an FXR blocker, has supportive data in organoids, experimental models, and people for blocking Covid infections and/or reducing its severity nature.com/articles/s4158…

Great to be part of this study describing the potential of an approved, inexpensive, off-patent drug for liver disease in combatting Covid infections Inst of Infection Veterinary & Ecological Sciences University of Liverpool News Centre of Excellence for Long-acting Therapeutics UK-ICN #SARSCoV2 nature.com/articles/s4158…

This important work was a brilliant collaborative effort led by University of Cambridge. The work undertaken by CELT scientists was a joint effort between James Stewart 🦠🌿 and CELT Pharmacology. Congratulations to everyone involved. Andrew Owen James Stewart 🦠🌿 Inst of Systems, Molecular & Integrative Biology #covid19

An off-patent liver disease drug could prevent #COVID19 infection, a new nature study has found. Faculty of Health and Life Sciences scientists played a key role in the collaborative study, which involved a unique mix of ‘mini-organs’, donor organs, animal studies & patients. news.liverpool.ac.uk/2022/12/05/off…

#HLSPosterDay2022 Sondus from Inst of Infection Veterinary & Ecological Sciences

Exciting new study from the lab published today! Excellent collaboration between Bicycle Therapeutics and academic labs to characterise new antiviral modality against #SARSCoV2 : Bicycle #antiviral #COVID19 #Spike rdcu.be/deGq1

Huge thank you to all teams that took part in this study: Bicycle Therapeutics James Stewart 🦠🌿 Andrew Owen markohyvonen bsky social and members of Leo James' Lab group Marina Vaysburd (twiterless), @AnnaAlbecka Guido Papa and Donna Mallery

Saturday high tide, sunset and surf at beautiful peaceful Cemaes bay Cemaes Bay Tonya O'Donnell #cemaesbayswimmers #Anglesey

Great to be in Japan 🇯🇵 presenting our latest #Covid_19 data at the 日本ウイルス学会The Japanese Society for Virology Japanese Society for Virology meeting. Inst of Infection Veterinary & Ecological Sciences University of Liverpool News Such welcoming hosts